OKYO Pharma Limited Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
OKYO Pharma Limited (OKYO) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $1.87 per share as of 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2025-07-18
- 2025-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $1.87.
- 2024-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $4.34.
- 2023-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $4.41; Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 as first filed $6.79.
- 2022-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $4.78; Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 as first filed $7.36.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2025-03-31 | $1.87 20-F · filed 2025-07-18 | |
| 2024-03-31 | $4.34 20-F · filed 2025-07-18 | |
| 2023-03-31 | $4.41 20-F · filed 2025-07-18 | $6.79 20-F · filed 2023-08-15 |
| 2022-03-31 | $4.78 20-F · filed 2024-08-13 | $7.36 20-F · filed 2022-08-15 |
| 2021-03-31 | $6.21 20-F · filed 2023-08-15 | |
| 2020-03-31 | $5.58 20-F · filed 2022-08-15 |